Source: BioPortfolio

PQ Bypass: PQ Bypass Announces 100th Patient in Clinical Study to Evaluate Percutaneous FemPop Bypass for Extremely Long Blockages in Leg Arteries

DETOUR Procedure Designed to Move Treatment from Inpatient to Outpatient SettingSilicon Valleybased medical device company PQ Bypass announced today the 100th patient in the DETOUR2 Clinical Trial which evaluates the safety and effectiveness of the minimal...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Richard Ferrari's photo - Chairman & CEO of PQ Bypass

Chairman & CEO

Richard Ferrari

CEO Approval Rating

78/100

Read more